Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Exenatide/insulin-detemir/insulin-glargine/insulin-lispro/metformin

Lipohypertrophy and GERD-like side effects

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ayub T, et al. What A Simple Switch Can Achieve; A Case Of Severe Insulin-induced Lipohypertrophy. Journal of the Endocrine Society 7 (Suppl. 1): A521 abstr. SAT108, Nov 2023. Available from: URL: https://dx.doi.org/10.1210/jendso/bvad114.973 [abstract] Ayub T, et al. What A Simple Switch Can Achieve; A Case Of Severe Insulin-induced Lipohypertrophy. Journal of the Endocrine Society 7 (Suppl. 1): A521 abstr. SAT108, Nov 2023. Available from: URL: https://dx.doi.org/10.1210/jendso/bvad114.973 [abstract]
Metadaten
Titel
Exenatide/insulin-detemir/insulin-glargine/insulin-lispro/metformin
Lipohypertrophy and GERD-like side effects
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56215-3

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Immune-globulin

Case report

Rituximab

Case report

Teclistamab

Case report

Cotrimoxazole